Wang Y, Ling S, Feng H, Hua J, Han Z, Chai R
Int J Gen Med. 2025; 18:1047-1073.
PMID: 40026815
PMC: 11871936.
DOI: 10.2147/IJGM.S508197.
Lai Y, Liu J, Hu X, Zeng X, Gao P
Sci Rep. 2025; 15(1):5876.
PMID: 39966502
PMC: 11836354.
DOI: 10.1038/s41598-025-88435-0.
Li P, Lin Y, Ma H, Zhang J, Zhang Q, Yan R
Cell Death Discov. 2025; 11(1):43.
PMID: 39904996
PMC: 11794895.
DOI: 10.1038/s41420-025-02324-z.
Wang S, Shen S, Cheng N, Zhou W, Yu W, Liang D
Eur J Med Res. 2024; 29(1):608.
PMID: 39702336
PMC: 11657712.
DOI: 10.1186/s40001-024-02194-8.
Wu Y, Lin S, Chen H, Zheng X
Cell Mol Life Sci. 2024; 82(1):1.
PMID: 39656315
PMC: 11631829.
DOI: 10.1007/s00018-024-05536-1.
m6A methyltransferase METTL3 promotes non-small-cell lung carcinoma progression by inhibiting the RIG-I-MAVS innate immune pathway.
Huang T, Ao X, Liu J, Sun C, Dong Y, Yin X
Transl Oncol. 2024; 51:102230.
PMID: 39626341
PMC: 11652952.
DOI: 10.1016/j.tranon.2024.102230.
R-loops' m6A modification and its roles in cancers.
Qiu Y, Man C, Zhu L, Zhang S, Wang X, Gong D
Mol Cancer. 2024; 23(1):232.
PMID: 39425197
PMC: 11487993.
DOI: 10.1186/s12943-024-02148-y.
NAT10 resolves harmful nucleolar R-loops depending on its helicase domain and acetylation of DDX21.
Su K, Zhao Z, Wang Y, Sun S, Liu X, Zhang C
Cell Commun Signal. 2024; 22(1):490.
PMID: 39394182
PMC: 11468200.
DOI: 10.1186/s12964-024-01869-3.
N-methyladenosine-mediated upregulation of LNCAROD confers radioresistance in esophageal squamous cell carcinoma through stabilizing PARP1.
Shi X, Zhang X, Huang X, Zhang R, Pan S, Huang S
Clin Transl Med. 2024; 14(10):e70039.
PMID: 39367700
PMC: 11452732.
DOI: 10.1002/ctm2.70039.
Recruitment of the mA/m6Am demethylase FTO to target RNAs by the telomeric zinc finger protein ZBTB48.
Nabeel-Shah S, Pu S, Burke G, Ahmed N, Braunschweig U, Farhangmehr S
Genome Biol. 2024; 25(1):246.
PMID: 39300486
PMC: 11414060.
DOI: 10.1186/s13059-024-03392-7.
A model for a dual function of N-methyladenosine in R-loop regulation.
Abakir A, Ruzov A
Nat Genet. 2024; 56(10):1995-1998.
PMID: 39289548
DOI: 10.1038/s41588-024-01905-5.
METTL3 silencing inhibits ferroptosis to suppress ovarian fibrosis in PCOS by upregulating m6A modification of GPX4.
Shen C, Jiang Y, Lin J, Guo Q, Fang D
J Mol Histol. 2024; 55(6):1163-1175.
PMID: 39261364
DOI: 10.1007/s10735-024-10257-7.
Deciphering NF-kappaB pathways in smoking-related lung carcinogenesis.
Thapa R, Moglad E, Goyal A, Bhat A, Almalki W, Kazmi I
EXCLI J. 2024; 23:991-1017.
PMID: 39253534
PMC: 11382301.
DOI: 10.17179/excli2024-7475.
The roles and mechanisms of coding and noncoding RNA variations in cancer.
Kim S, Na M, Yoon S, Shin E, Ha J, Jeon S
Exp Mol Med. 2024; 56(9):1909-1920.
PMID: 39218979
PMC: 11447202.
DOI: 10.1038/s12276-024-01307-x.
A prognostic signature based on genes associated with m6A/m5C/m1A/m7G modifications and its immunological characteristics in clear cell renal cell carcinoma.
He W, Cong Z, Niu C, Cheng F, Yi T, Yao Z
Sci Rep. 2024; 14(1):18708.
PMID: 39134681
PMC: 11319670.
DOI: 10.1038/s41598-024-69639-2.
RNA biogenesis and RNA metabolism factors as R-loop suppressors: a hidden role in genome integrity.
Luna R, Gomez-Gonzalez B, Aguilera A
Genes Dev. 2024; 38(11-12):504-527.
PMID: 38986581
PMC: 11293400.
DOI: 10.1101/gad.351853.124.
METTL3 promotes immature dental pulp stem cells-induced angiogenesis by regulating ETS1 mRNA stability in an mA-HuR-dependent manner.
Qin J, Zou L, Lu F, Liu F, Min Q, Zhu L
Odontology. 2024; 113(1):305-317.
PMID: 38969870
DOI: 10.1007/s10266-024-00977-3.
COL1A1, mediated by m6A methylation of METTL3, facilitates oral squamous cell carcinoma cell growth and metastasis.
Lv R, Yao Y, Dong J, Chen Q
Odontology. 2024; 113(1):191-200.
PMID: 38900231
DOI: 10.1007/s10266-024-00962-w.
TERRA transcripts localize at long telomeres to regulate telomerase access to chromosome ends.
Bettin N, Querido E, Gialdini I, Grupelli G, Goretti E, Cantarelli M
Sci Adv. 2024; 10(24):eadk4387.
PMID: 38865460
PMC: 11168465.
DOI: 10.1126/sciadv.adk4387.
LINC00606 promotes glioblastoma progression through sponge miR-486-3p and interaction with ATP11B.
Dong N, Qi W, Wu L, Li J, Zhang X, Wu H
J Exp Clin Cancer Res. 2024; 43(1):139.
PMID: 38725030
PMC: 11080186.
DOI: 10.1186/s13046-024-03058-z.